Biosensor for Detecting Viscosity Changes
Researchers at Purdue University have developed and designed miniaturized platforms for analyzing biopharmaceutical degradation. This technology provides significant advantages to current macroscale systems and allows for rapid testing of pharmaceuticals outside of the quality control laboratory using small sample volumes. The method has been proven with several different biopharmaceutical formulations and can discriminate as little as 5 percent degradation of insulin in a solution. This technology is a new tool for biopharmaceutical analysis and could readily be implemented at key points of the pharmaceutical delivery chain.
Requires only a small sample to test Eliminates the need for lab testing Eliminates waste by discriminating degraded vs. intact product Eliminates risk of using inactive biopharmaceutical for patients
Insulin testing Biopharmaceutical efficacy tests
Steve WereleyPurdue Microfluidics GroupPurdue Mechanical Engineering
United States
None
美國
